Lead optimisation
Hit to lead
Assay Development
Therapeutic area
  • Inflammation

Project Aim

To develop small molecule inhibitors of MIF for the treatment of inflammatory diseases


Lead series with more desirable chemical properties than those previously disclosed from competitor MIF programmes

Target Class

Inflammatory Cytokine


Small molecule

Current Status

Lead optimisation with in-vivo proof of concept planned

Intellectual Property

Opportunity to create a protective IPR portfolio



Key Contact

  • In submitting your personal data via this form, you consent to being contacted via the details provided so that your enquiry can be responded to. A backup of your data will be held but only authorised individuals will be able to access your data. If you would like your data to be removed, please email
    Please see our Privacy policy in relation to the personal data you submit to us through this page.
  • We would love to send you information about LifeArc news and events. Please let us know if you would like us to contact you by selecting one of the following options:
All Licensing Opportunities